Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martinus T. M. Tulp is active.

Publication


Featured researches published by Martinus T. M. Tulp.


Archive | 2001

4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity

Josephus H. M. Lange; Cornelis G. Kruse; Jacobus Tipker; Martinus T. M. Tulp; Bernard J. Van Vliet


Journal of Medicinal Chemistry | 1997

5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.

Kuipers W; Cornelis G. Kruse; I. van Wijngaarden; P. J. Standaar; Martinus T. M. Tulp; N. Veldman; Anthony L. Spek; Adriaan P. IJzerman


Pharmacopsychiatry | 1993

Preclinical Evidence on the Psychotropic Profile of Fluvoxamine

Berend Olivier; L. Bosch; A. van Hest; J.A.M. van der Heyden; J. Mos; G. van der Poel; J. Schipper; Martinus T. M. Tulp


Archive | 1987

Aryl-substituted (N-piperidinyl)methyl- and (N-piperidinyl) methylazoles having antipsychotic properties

Ineke Van Wijngaarden; Cornelis G. Kruse; Johannes A. M. van der Heyden; Martinus T. M. Tulp


Archive | 2000

Phenylpiperazines as serotonin reuptake inhibitors

Hes Roelof Van; Der Heijden Johannes A. M. Van; Cornelis G. Kruse; Jacobus Tipker; Martinus T. M. Tulp; Gerben M. Visser; Vliet Bernard J Van


Drug Development Research | 1992

Ethopharmacological studies differentiate the effects of various serotonergic compounds on aggression in rats

Jan Mos; Berend Olivier; Martinus T. M. Tulp


Archive | 1988

Tertiary arylethyl amine derivatives having opiate-antagonistic activity

Wijngaarden Ineke Van; Hartog Jacobus A. J. Den; Martinus T. M. Tulp; Marinus W. Lobbezoo


Archive | 1987

Phenyl-substituted (N-piperazinyl) methylazoles for treating affections in the central nervous system

Ineke Van Wijngaarden; Cornelis G. Kruse; Johannes A. M. van der Heyden; Martinus T. M. Tulp


Archive | 1998

Substituted pyridylmethylpiperazine and -piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders

Hartog J.A.J. Den; R.W. Feenstra; Cornelis G. Kruse; S.K. Long; Martinus T. M. Tulp


Archive | 1998

Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity

Jacobus A. J. den Hartog; Gerben M. Visser; Johannes W. C. M. Jansen; Eric Ronken; Martinus T. M. Tulp; Jan H. Reinders; Gerrit P. Toorop

Researchain Logo
Decentralizing Knowledge